oxybutynin has been researched along with Bradycardia in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report describes a patient who developed severe bradycardia due to transdermal fentanyl." | 7.79 | Case report of severe bradycardia due to transdermal fentanyl. ( Hawley, P, 2013) |
| "This case report describes a patient who developed severe bradycardia due to transdermal fentanyl." | 3.79 | Case report of severe bradycardia due to transdermal fentanyl. ( Hawley, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K | 1 |
| Kobayashi, S | 1 |
| Suzuki, M | 1 |
| Miyata, K | 1 |
| Takeuchi, M | 1 |
| Yamada, T | 1 |
| Honda, K | 1 |
| Hawley, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate[NCT01777217] | Phase 4 | 8 participants (Actual) | Interventional | 2013-02-28 | Terminated (stopped due to Terminated) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The AUASS score range is 1-7 (mild), 8-19 (moderate) and 20-35 (severe). The AUASS asks 7 questions scored 0-5, the scores are summed for the total score. (NCT01777217)
Timeframe: baseline and 16 weeks
| Intervention | Scores on a scale (Median) |
|---|---|
| Solifenacin Succinate | 9.4 |
| Placebo | 6.7 |
2 other studies available for oxybutynin and Bradycardia
| Article | Year |
|---|---|
M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Topics: Animals; Benzofurans; Bradycardia; Calcium; Carbachol; Cells, Cultured; Cytosol; Dose-Response Relat | 2002 |
Case report of severe bradycardia due to transdermal fentanyl.
Topics: Analgesics, Opioid; Bradycardia; Canada; Female; Fentanyl; Humans; Middle Aged; Ovarian Neoplasms; T | 2013 |